Voluven 250 ml | 合法藥品大搜索

Indications. Voluven® is indicated for treatment of hypovolemia due to acute blood loss when crystalloids alone are not considered sufficient. Hypovolemia. Read More

(6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) is a 3rd generation starch plasma volume expander available in over 100 countries worldwide. Read More

Voluven® is a 6% hydroxyethyl startch 130/0.4 in 0.9% sodium chloride solution, which is indicated for the treatment of hypovolaemia. It is derived from waxy ... Read More

​​HES 130/0.4 in 0.9% sodium chloride solution - The latest generation of starches. Features; Benefits; Indications; Product ... Read More

AUSTRALIAN PRODUCT INFORMATION - VOLUVEN® 6% (HYDROXYETHYL. STARCH 130/0.4 IN A BALANCED ELECTROLYTE SOLUTION). Page 1 of 12. Read More

Indications. Voluven® is indicated for the treatment and prophylaxis of hypovolaemia in adults and children. It is not a substitute for red blood cells or coagulation ... Read More

Fresenius Kabi India Pvt. Ltd. is a 100% subsidiary of Fresenius Kabi AG Germany. Fresenius Kabi AG is a part of the Fresenius Health Care Group which is ... Read More

2021年4月16日 — Voluven® 500 mL. Backorder Notification. Dear Valued Customer,. Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay ... Read More

PRODUCT MONOGRAPH. VOLUVEN ®. 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection. Fresenius Kabi Canada. A division of Calea Ltd. Read More